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Abstract

Background: The opioid crisis has stemmed from the undertreatment of pain. This inadequacy
has led to increased use of opioids and a rapid rise in opioid-related fatalities. Opioids are used
extensively in the perioperative period because of their beneficial pain-relieving and consciousaltering properties. Patients are often sent home with prescriptions for these habit-forming
medications, leading to tolerance, addiction, and potential overdoses. This is especially true for
very painful procedures, such as orthopedics. As a result, healthcare providers are at the forefront
of making a change in the trajectory of the opioid crisis. One method is to find safe and effective
non-opioid modalities to control postoperative pain. One such modality is the use of cryotherapy.
Methods: A comprehensive search was conducted using Google Scholar and PubMed databases
to find research articles within the last 6 years on the effects of cryotherapy on postoperative
opioid consumption following orthopedic surgery.
Results: Five research articles were selected for review. The articles investigated the effect of
cryotherapy on postoperative opioid consumption in orthopedic surgery patients. It was shown
that cryotherapy reduces postoperative opioid consumption following orthopedic surgery.

Keywords: Cryotherapy, postoperative opioid consumption, postoperative pain,
orthopedic surgery
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An Educational Module Explaining The Effect of Cryotherapy on Postoperative Opioid
Consumption In Orthopedic Surgery: A Quality Improvement Project.
The United States is engaged in one of the most alarming public health crises to date.
From the turn of the century to 2017, opioid-related deaths have increased from 0.3 to 9 per
100,000 people.1 In 2020, that rate has soared to 17.8 per 100,000 people.2 Although the origin is
multi-factorial, healthcare and the over-prescription of opioids have been to blame. As the
incidence of pain rises, patients are demanding quick fixes to resolve health problems
instantaneously. The fast action and efficacy of opioids have led to increased prescriptions and
opioid drug use.3 Most opioid abusers begin their addiction from prescription medications, some
of which resulting from chronic pain after surgical procedures.4 Each time a patient refills an
opioid prescription after surgery, there is a 44% increase in the rate of opioid misuse.5
Opioids are used extensively in the perioperative surgical period because of their ability
to induce hypnotic states, blunt hemodynamic responses to surgical stress, and provide pain
relief.6 Untreated acute pain can result in delirium, poor wound healing, longer hospital stays,
increased cost, and the development of chronic pain, resulting in more opioid use.7 A vicious
cycle occurs, leading to further opioid addiction and a rise in opioid-related deaths.
Background
In the 1990s, undertreated chronic pain became a mainstay in United States medicine due
to growing patient expectations of fast and complete pain relief. Additionally, the aging
population, improved survival rates of injuries and illnesses, and the increased frequency and
complexity of surgery have contributed to the growing number of those living with chronic
pain.3 Historically, the less frequently encountered chronic pain patient was referred to cognitive
behavioral therapy. When insurance became less inclined to cover such treatments, the demand
for pain-relieving medications led to an explosion in the financially driven pharmaceutical
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market, resulting in opioids becoming commonplace in medicine.3 The efficacy of opioids and a
saturated market have led to an easily accessible opioid supply causing tolerance, addiction, and
overdose-related fatalities.
The opioid crisis has been difficult to curb because it is multi-factorial and is constantly
evolving, but when used appropriately, the therapeutic effect of opioids is indeed beneficial.8 The
increase in opioid use stems from the undertreatment of acute pain. As pain remains inadequately
treated, chronic pain develops, and more prescriptions are written. As a result, more individuals
are exposed to opioids, leading to dependence and addictions.8 Despite the high number of
opioids prescribed to treat chronic pain, patient outcomes remain poor. Long-term opioids used
to treat chronic pain can lead to a decreased quality of life, compromised mental and physical
function, and lower return to work rates while still not adequately treating pain. The lack of pain
management from opioids for chronic pain sufferers leads to centralized pain syndromes and
neuropathic pain, resulting in more opioid prescriptions.9 Even when prescriptions end, a
saturated market has led to the use of easily accessible illicit opioids.10
In the perioperative setting, opioids have become the mainstay treatment of the fifth vital
sign: pain. Intraoperatively, their high efficacy and fast onset make them ideal adjuncts for pain
control. High doses of opioids with long-lasting effects are often prescribed in the postoperative
setting for temporary pain. The repeated use of these opioids suppresses the production of
endogenous opioids, leading to physiologic dependence.4
Opioids induce their pain-eliminating effect on mu-opioid receptors. These receptors
reside in brainstem neurons that are also responsible for controlling breathing.11 As opioids are
repeatedly administered, a physiologic tolerance develops, requiring an increase in dosing to
achieve an equal analgesic effect. As dosing increases, so do the adverse effects, including
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respiratory depression.8 In non-medical settings that lack trained personnel and anecdotes, it can
be fatal. Therefore, a solution needs to be found in which pain is adequately controlled while
reducing the need for opioids.
Scope of the Problem
Even though the United States comprises about 5% of the world’s population, it is
responsible for roughly 80% of its opioid consumption.4 In 2016, 42,000 deaths were opioidrelated.10 According to the Centers for Disease Control and Prevention (CDC), that number rose
to almost 92,000 in 2020.2 The rapid and severe rise of opioid-related deaths led to an
announcement from the United States National Safety Council that a person is more likely to die
from an opioid overdose than a vehicle crash. This elevates opioid overdose to the fifth most
common cause of death.12 The absence of a solution will result in a continued surge in these
alarming statistics.
Although opioid use was historically limited to Caucasian males, it now spans multiple
patient demographics and socioeconomic populations. Opioid use is rising in low socioeconomic
areas, middle-class communities, and counties dominated by manufacturing and service
industries.3 At times, the lack of community resources leads to opioids as the remedy for pain.
Additionally, opioids are being utilized throughout the entire lifespan. The prevalence of
neonates diagnosed with neonatal abstinence syndrome is rapidly increasing as the number of
pregnant women filling opioid prescriptions rises.4 Teenagers and young adults participating in
competitive sports are being prescribed opioids for sports-related injuries.4 As life expectancy
lengthens, the rising prevalence of neuromuscular and autoimmune disorders in the aging
population increases opioid use in this patient demographic.3 As more patient populations are
exposed to opioids, the consequences of this crisis will continue to grow.
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Consequences of the Problem
As more individuals become exposed to opioids, the incidence of tolerance, dependence,
addiction, and opioid-related deaths will continue to escalate. From 1999-2013, the average rate
of rise in opioid-related deaths was 8% per year. Since then, opioid-related deaths have increased
by an average of 71% per year.1 This includes an increase of 56% from 2019 to 2020.2 Without
action, this number will continue to climb annually.
In addition to fatalities, opioid use leads to other health problems, including hyperalgesia,
pneumonia, ileus formation, as well as infection and cancer progression from a weakened
immune response.4 Studies have shown that opioid-related health problems, especially
postoperatively, lead to prolonged hospital stays and increased costs. Additionally, the risk of
hospital readmission rises by almost 40%, and the risk of inpatient mortality increases 3.4-fold in
postoperative patients with opioid-related health problems.13 Opioid-related morbidity and
mortality are surging from a potentially rectifiable problem.
Knowledge Gaps
One knowledge gap is genetics’ role in the effects of opioids in individual patients.
Pharmacogenetics is a new field of research that studies how an individual's genetic makeup
affects the action of opioids and can potentially predict the risk of opioid addiction. Whereas
some patients' genetics may require more opioids, others may need less.14 Since opioids are often
prescribed systematically, a better understanding of how a patient may react to opioids could
help tailor pain management individually, reducing the risk of opioid addiction.
A second potential knowledge gap is the identification of risk factors that may predict the
likelihood of opioid abuse. Some literature states that long-term opioid use postoperatively is
independent of previous opioid use.15 More recent studies contradict this claim, showing that

9
patients who used opioids before surgery were less likely to take opioids 90 days after surgery
than opioid naïve patients.16 Therefore, further research should focus on specific patient factors
that may predict potential opioid misuse. This information can help anesthesia professionals
tailor anesthetic to those who may be prone to opioid abuse.
Proposal Solution
Curbing the opioid crisis cannot be done without addressing the pain needs of surgical
patients. Surgeons and anesthesia providers are in prominent positions to reduce opioid use while
adequately treating pain. Although a more conservative approach to opioid prescriptions is
beneficial, there is a need for safer and more effective nonopioid treatments.11
With the understanding that curbing the opioid crisis will take interventions from
multiple fronts, the proposed solution attempts to reduce the number of opioids used and
prescribed throughout the perioperative setting. Finding safe and effective nonopioid methods to
reduce pain will help decrease the number of opioids with which patients are leaving hospitals.
This is especially true for excruciating procedures and those that have been shown to require
more opioids than others. One area of research is cryotherapy's effect on postoperative opioid
consumption compared to traditional opioid modalities in orthopedic surgery patients. The
efficacy of cryotherapy could help decrease the number of prescription opioids being used
postoperatively, curbing addiction and reducing opioid-related fatalities.
Rationale
In the United States, about 51 million people undergo an elective inpatient surgical
procedure annually, and over 80% of them are prescribed opioids postoperatively.15 Long-term
opioid use can be triggered by opioids prescribed during the perioperative period and could be
surgery specific. It was shown that two of the procedures most associated with long-term opioid
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use were orthopedic procedures: total knee and total hip arthroplasties.15 Long-term opioid use
postoperatively may be independent of past opioid use. Opioid-tolerant patients require higher
dosing and more prescriptions, whereas opioid naïve patients can become addicted to the pain
relief that accompanies new prescription opioids. In each scenario, surgical pain needs to be
addressed. Surgeons and anesthesia providers are in a challenging position to balance two critical
clinical scenarios: the need to adequately treat acute surgical pain and the prevention of
excessive opioid use postoperatively.15
Literature Review
This literature review aims to investigate established research on the effect of cryotherapy
on postoperative opioid consumption in orthopedic surgery patients. The type of cryotherapy
modality is not distinguished nor compared in this review. The literature search was conducted
using the following PICO components:
Population (P): Patients undergoing orthopedic surgery
Intervention (I): The use of cryotherapy
Comparison (C): Traditional opioid modalities
Outcomes (O): Postoperative opioid consumption
Eligibility Criteria
The research articles included in this literature review were subjected to inclusion criteria
to ensure the reliability of the evidence presented. Articles chosen must have been published
within the last 6 years, written in English, and had full-text availability. Exclusion criteria
included research regarding the pediatric patient population, the comparison of different
cryotherapy modalities, and the comparison of cryotherapy to other pain-relieving methods other
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than opioids. The studies chosen were believed to have met the objective of this literature
review.
Information Sources
Research studies were found with the use of Google Scholar and PubMed databases.
Keywords and appropriate Boolean operators were used to find articles with which to apply the
inclusion and exclusion criteria. Database sources used for research and full-text articles were
accessed through the Florida International University (FIU) library web portal services.
Search Strategy
Using keywords and Boolean operators led to a search that included: cryotherapy AND
postoperative opioid consumption, OR postoperative opioid consumption AND orthopedic
surgery. After implementing filters to find the highest level of evidence that met the inclusion
criteria, PubMed returned 50 research articles. Using the same keywords, Boolean operators, and
filters, Google Scholar returned 344 studies for 394 research articles. The results were imported
into the reference program Endnote. Duplicate reports were removed, and papers were filtered
based on title to find studies that matched the objective of this literature review.
The titles of 17 articles were approved for a review of the abstract. Investigation of the
abstract resulted in the full-text analysis of 12 reports. Studies that were removed included
pediatric patient populations, the comparison of different cryotherapy modalities, and
comparison to other nonopioid pain-relieving modalities, such as peripheral nerve blocks and
intra-articular injections of local anesthetics. This process resulted in five articles for literature
review.
Results
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Study Characteristics

All of the articles investigated for this literature review analyzed the effects of
cryotherapy on postoperative opioid consumption in patients undergoing orthopedic surgery
(Appendix A). Three studies were randomized controlled trials17-19 and two were systematic
reviews.20,21 Two randomized controlled trials were non-blinded, whereas one was blinded. All
three compared postoperative pain and opioid consumption between a cryotherapy group and a
control group. The two systematic reviews focused on research that investigated the use of
nonopioid modalities to combat postoperative pain.
Results of Individual Studies
Brouwers et al.17 used a non-blinded randomized controlled trial to investigate whether
the use of cryotherapy reduced pain and opioid consumption after orthopedic surgery. A total of
102 patients were divided into two groups: one group received cryotherapy for the first 7 days
postoperatively, while the control group did not. Patients in the cryotherapy group were given the
same cryotherapy system to use in the hospital and at home with a schedule to follow. The
primary outcomes of pain and postoperative opioid use were assessed daily during the first week,
and at 2 and 6 weeks postoperatively. In this study, oxycodone was prescribed for needed
analgesia.
It was shown that the cryotherapy group reported less pain and consumed less opioid
medication during the first week postoperatively than the control group. Twenty-one percent of
patients in the cryotherapy group required breakthrough analgesia with oxycodone compared to
40% of the control group.17 The cryotherapy group needed 47 oxycodone pills during the first
week to combat breakthrough analgesia, whereas 97 oxycodone pills were used in the control
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group. Cryotherapy resulted in a 48% reduction in postoperative opioid consumption during the
first week.17 The study also showed that although reported pain levels were less in the
cryotherapy group at 2 and 6 weeks postoperatively, they were not considered statistically
significant.
This study was a randomized controlled trial, providing level I evidence. However, there
were limitations. The most significant limitation was that self-reporting pain scores and opioid
consumption following the first week could cause some results to be inaccurate and potentially
unreliable. Additionally, if cryotherapy schedules were not followed precisely, it could have led
to different outcomes. Finally, a placebo effect could alter the results since the trial was not
blinded.17
A similar non-blinded randomized controlled trial was performed by Kuyucu et al.18 that
involved 60 patients undergoing total knee arthroplasty randomly assigned to the cryotherapy
group or the control group. For 27 patients, cryotherapy was performed 2 hours preoperatively, 6
hours postoperatively, and then 2 hours every day for the first 4 postoperative days. The other 33
patients did not receive cryotherapy. All patients were operated on by the same surgeon using the
same surgical technique. The average pain score in the first postoperative week in the control
group was 3.4 on a 10-point scale compared to 2.7 in the cryotherapy group. This resulted in
fewer postoperative analgesics consumed by the cryotherapy group.18 The major limitation of
this level I evidence was the small sample size. Additionally, more patients in the control group
could affect the average pain score reported. Finally, reporting pain scores is a subjective
measurement, which can be altered based on each patient's perception of pain and pain tolerance
levels.
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A secondary outcome used The Knee Society Scoring System (KSS) to evaluate pain,
range of motion, and operative knee stability. It was found that the cryotherapy group scored
higher on the KSS, indicating less pain, greater range of motion, and more stability than the
control group.18 Although not wholly aligned with the objective of this review, this study
indicates a potential area of further research regarding the use of cryotherapy in orthopedic
surgery.
The final randomized controlled trial performed by Thijs et al.19 was double-blinded and
investigated the pain scale rating and opioid consumption of patients undergoing total knee
arthroplasty. Sixty patients were randomly divided into a cryotherapy group and a control group.
Third-party medical staff performed the therapy, ensuring that researchers remained blinded. The
30 patients in the control group were connected to the cryotherapy apparatus but received
treatment at 21 degrees Celsius as opposed to cryotherapy at 10-12 degrees Celsius. Therapy was
given on a fixed schedule for the first 7 postoperative days. The same surgeon performed the
procedure using the same surgical technique and closure. All patients received the same
perioperative care except for the cryotherapy itself. Additionally, all patients were prescribed the
same rehabilitation schedule. The narcotic used for breakthrough pain in the study was
Tramadol.
The cryotherapy group reported a lower pain score postoperatively during the first 7 days
than the control group. Their pain was also assessed before and after each cryotherapy treatment.
Although both groups reported a decrease in pain after each treatment, it was only statistically
significant in the cryotherapy group. Over the first postoperative week, the cryotherapy group
consumed 2,350 milligrams (mg) of Tramadol for breakthrough pain compared to 4,150 mg in
the control group.19 Cryotherapy decreased postoperative opioid consumption by almost 57%.
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The small sample size was a limitation to this study, and outside factors could influence the selfreporting of pain scores, which the authors stated. However, the objective use of the number of
opioids consumed may help reduce this limitation.
Chughtai et al.20 performed a systematic review to investigate nonpharmacologic pain
management following orthopedic surgery. The authors used PubMed, EBSCO Host, and
SCOPUS literature search and included 52 articles in the study. Based on the research, the
authors concluded that cryotherapy lowers pain scores and decreases postoperative opioid
consumption following orthopedic surgery compared to control groups.20 Although the articles
referenced are more than 6 years old, the results presented correlate with more recent research.
The authors state that the submitted evidence supports cryotherapy use in the perioperative
period as a nonpharmacologic modality to decrease pain and limit postoperative opioid
consumption.20 Articles presented that contradicted this stance were believed to have significant
flaws in study design, substantial limitations, or obvious bias.
Ni et al.21 performed a systematic review based on evidence found from a literature
search using the Cochrane Library, MEDLINE, and Embase. Using relevant keywords, the
authors sought randomized controlled trials comparing cryotherapy to a control group and the
effects on pain and opioid consumption post-total knee arthroplasty. After exclusion criteria were
implemented, 12 articles were included in the review. The authors found that cryotherapy has
been shown to lower pain scores on postoperative day two and decrease the number of analgesics
necessary during the postoperative period.21 However, differences in pain scores on
postoperative day 1 were non-significant. This could be a result of the lingering effects of
anesthesia modalities. According to the authors, more randomized controlled trials are needed.
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Literature Review Discussion

Summary of the Evidence

The pathophysiology behind cryotherapy and its pain-limiting effects is not fully
understood but is believed to have multiple mechanisms. Applying cold to the tissues lowers the
temperature, causing vasoconstriction, which decreases blood flow. This decrease in blood flow
reduces the inflammatory response to injury, decreasing swelling and pain sensation.17 The
reduction in temperature also reduces nerve conduction velocity, decreasing pain sensed by the
body.18 Finally, cooling the synovial fluid may reduce prostaglandins, which are pain mediators,
limiting pain.20 As a result, cryotherapy attacks pain from many angles, making it a multi-modal
intervention and increasing its efficacy.
The evidence suggests that cryotherapy in the postoperative setting reduces opioid
consumption following orthopedic surgery. Compared to control groups, patients undergoing
cryotherapy have been shown to have less pain and consume significantly fewer opioids. It was
demonstrated that cryotherapy could decrease the number of patients requiring breakthrough
analgesia and reduce postoperative opioid consumption by up to 57%.19 Additionally, fewer
opioids help to reduce adverse effects, including nausea, vomiting, constipation, and respiratory
depression.17 Less pain also results in greater patient satisfaction, decreased length of hospital
stay, and decreased cost.3 Further research can explore the effect of cryotherapy on postoperative
range of motion, stability, daily function, and physical therapy.
Literature Review Conclusion
Curbing the opioid crisis will require using effective and opioid-free pain modalities. One
area of research is cryotherapy's effect on postoperative opioid consumption compared to
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traditional opioid modalities in patients undergoing orthopedic surgery. Cryotherapy has been
shown to decrease pain and reduce the number of opioids consumed postoperatively. As a result,
cryotherapy should be considered a standard pain modality to curb the opioid crisis.
Primary DNP Project Goal
With the understanding that curbing the opioid crisis will take interventions from
multiple fronts, the proposed solution attempts to reduce the number of opioids used and
prescribed throughout the perioperative setting. Finding safe and effective alternatives to pain
management may result in increased quality of life, less exposure to opioids, and less opioid
abuse and overdoses.16 This is especially true for excruciating procedures and those that have
been shown to require more opioids than others.
The primary goal was to improve the knowledge of Certified Registered Nurse
Anesthetists (CRNAs) on cryotherapy in orthopedic surgery patients to decrease postoperative
opioid consumption. The objective was to examine traditional postoperative pain management
with the use of opioids and replace them with evidence-based interventions to reduce opioid
consumption. The efficacy of cryotherapy could help decrease the number of prescription
opioids being used postoperatively, curbing addiction and decreasing opioid-related fatalities.
SMART Goals and Outcomes
Specific
CRNAs would understand evidence-based interventions for cryotherapy during the
perioperative period for patients undergoing orthopedic surgery.
Measurable
The effectiveness of these interventions would be measured by analysis of a
questionnaire provided to participants before and after an educational intervention. The

18
knowledge of participants regarding the opioid crisis, opioids, postoperative pain management,
and cryotherapy would be assessed pre-and post-intervention. The goal was to increase
knowledge after the intervention compared to before.
Achievable
CRNAs would have advanced knowledge to collaborate on developing guidelines to
include cryotherapy during the perioperative period.
Realistic
CRNAs would be educated on the advantages of using cryotherapy during the
perioperative period. Providing education on cryotherapy is a realistic proposition as pain control
and opioid administration are highly prevalent in the perioperative setting. Even though
healthcare professionals work different schedules and variable hours, online educational modules
make education realistic in that perioperative personnel can partake in the education, regardless
of schedule.
Timely
The outcome of this initiative would be the increased knowledge of cryotherapy use in
the perioperative period and the development of guidelines for cryotherapy to be included in
perioperative pain management. As a questionnaire was provided immediately after the
educational intervention, evaluation of an increase in knowledge regarding cryotherapy was
time-efficient.
Program Structure
The successful use of cryotherapy during the perioperative period would require a
collaborative effort from multiple disciplines. An assessment was performed to identify the
stakeholders and the value of this project. An analysis of the project's strengths, weaknesses,
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opportunities, and threats would be utilized to evaluate the characteristics of the program's
development.
The first step of the assessment was to identify critical stakeholders that this project
affects. A stakeholder is a person or group with an interest or a concern in an organization or a
project. Stakeholders include patients, providers, insurance companies, organization donors, and
research committees in healthcare.22 With stakeholders identified, participants were presented
with a questionnaire to gauge the current knowledge level regarding the opioid crisis, opioids,
postoperative pain management, and cryotherapy. An educational intervention was performed for
perioperative providers addressing the importance of nonopioid pain management
postoperatively and how cryotherapy can decrease the number of opioids being consumed. After
the intervention, the same questionnaire was provided to compare the knowledge difference
before and after the educational intervention. Finally, the likelihood that each provider will adopt
cryotherapy in their practice was gauged.
Strengths
This project's strength was providing patients with evidence-based care to improve
outcomes. Decreasing postoperative pain while reducing the number of opioids consumed
provides a healthier experience for the patient while avoiding potential detrimental events from
the overuse of opioid pain medications. Improved patient outcomes offer part of an excellent
patient experience, which increases the likelihood of new patient referrals. This helps build an
organization's reputation that is attractive to current stakeholders.
A second strength was that the organization of interest advertises the use of technology,
research, and academics to provide comprehensive orthopedic care. Using evidence-based
practice to improve patient care would fit this self-prescribed culture. Introducing a program and
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intervention that requires collaborative, multidisciplinary care would support this organization's
advertisement.
Weakness
The major weakness of this project was the organization's requirement to acquire the
necessary technology to implement cryotherapy. Implementing this nonopioid pain management
intervention costs the organization for the equipment, training, and personnel needed to execute
this treatment successfully. How the decreased administration of opioids would balance this in
the postoperative period would remain to be seen.
A second weakness was the literature claiming that cryotherapy does not decrease opioid
consumption postoperatively. Chughtai et al.20 stated that these contradictions were flawed
research designs and noncompliance with the prescribed regimen. For outpatient procedures,
using resources on a technology that may not be used correctly could be viewed as a weakness
by stakeholders. However, improved education to perioperative personnel and patients strives to
improve compliance.
Opportunities
The opportunity for this project was for standardized use of cryotherapy during the
perioperative period. Standardization will prevent confusion from differences in surgeon
preference and alterations in nursing compliance. As a result, patients are provided the pain
management care needed to improve outcomes after surgery.
Secondly, the use of cryotherapy could offer the opportunity to decrease opioid
administration during the postoperative period. This can reduce the risk of adverse events during
recovery and result in faster discharge home or to the surgical floor. Long term, the fewer
opioids that are being prescribed reduce the risk of the development of tolerance and addiction.
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Threats
The primary threat to this project was the lack of support from surgeons, anesthesia
personnel, and nurses. Compliance will not be consistent without a collaborative effort to
implement this intervention and adverse patient outcomes can occur. Additionally, a lack of
investment may result in nurses not providing proper education to patients upon discharge
regarding usage. An absence of patient and caregiver understanding will also result in decreased
compliance, increased pain, and adverse patient outcomes.
Organizational Factors
As this intervention affects multiple healthcare disciplines, input from all of them will
help determine the effectiveness of the treatment and any changes that need to be made. Each
domain participating in the planning and evaluation will help increase support. Improved
awareness regarding the success of cryotherapy can lead to standardized protocols. Once
guidelines are in place, their effectiveness will need to be evaluated. Opioid consumption will be
monitored and compared to previous patients who received the same surgery to analyze
differences. At this time, feedback from the different disciplines regarding effectiveness, ease of
use, and necessary changes will be evaluated. This feedback will be used to improve the project
in the hope of continued positive patient outcomes.
Theoretical Framework
Theories provide a framework that is useful in practice and can offer questions to study
through research. Middle-range theories are believed to be more suited for guiding research as
they tend to be more specific and applicable to practice.23 A combination of two middle-range
theories served as the framework for the investigation to support these education interventions.
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The theory of comfort describes patients' holistic care as more than just controlling pain.
It includes physiological comfort, as well as mental, social, and environmental comfort.
Outcomes of this particular theory include decreased pain, fewer readmissions, increased patient
satisfaction, and improved psychological health.23 Successful care of a patient goes beyond the
immediate recovery period.
The second middle range theory was the theory of health-related quality of life. Although
at times broad and confusing, it has been recognized that quality of life is multidimensional and
includes physiological, psychological, and sociological domains.23 Similar to the theory of
comfort, the theory of health-related quality of life acknowledges the need to care for and protect
the mental aspect of a patient's health. The inability to control pain and the resulting tolerance
and addiction that may come from opioid use decreases patients' quality of life.
Methodology
Setting and Participants
The project included an online educational intervention provided to perioperative
healthcare professionals. The participants were CRNAs who have graduated from FIU’s nurse
anesthesia program. These participants were chosen because providing interventions to control
pain during the perioperative period is relevant to the education provided. Improved education on
pain-controlling modalities can improve health care practice and result in positive patient
outcomes.
As the schedules of healthcare professionals can be non-conducive to events at specific
times and places, an online educational module was established for learning to occur at the
provider's convenience. This helped to ensure that more professionals could partake in this
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educational experience. Relevant education materials were provided to enhance the learning of
these professionals.
Project Procedures
Before the project could move to the participants, approval from the FIU faculty had to
be obtained (Appendix B). Next, permission must have been granted from the Internal Review
Board (IRB) for the project to be launched (Appendices C & D). These approvals ensured that
the project was ethical and participants’ rights were protected.
Once approvals were received, CRNAs were recruited via personal e-mail to participate
in the project, and informed consent was signed (Appendices E & F). Participants then
completed a questionnaire regarding current knowledge related to the opioid crisis, effects of
opioids, cryotherapy, and postoperative pain management. This questionnaire provided a
baseline to compare the knowledge gained from the education intervention (Appendix G). Once
the initial questionnaire was finished, an education module was completed. The education
module presented information regarding the importance and relevance of the opioid crisis, the
physiology of cryotherapy, and the effect that cryotherapy has been shown to have on
postoperative opioid consumption (Appendix H). Additionally, conclusions were drawn
regarding the importance of the literature and the impact that cryotherapy can have on the opioid
crisis. Upon completion of the education module, the same questionnaire was completed again,
and the scores were compared. It was hypothesized that scores would increase after participation
in the module.
Protection of Human Subjects
Participants were informed of the project's purpose, the estimated time required, and that
participation was optional. Additionally, questionnaires remained anonymous, so there was no
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method to track answers back to the participant. Basic demographic information was asked for,
such as gender, age, and the number of years of service, but these were optional. It was also
shared that the project results would be displayed, and conclusions would be drawn based on the
answers provided. Finally, questions were asked regarding the potential for practice changes or
interest in further research from the participants to gauge the impact the education may have had
on future practice. Consents for participation were signed electronically to ensure that all
participants agreed that they had been adequately informed regarding their part of the project.
Data
Data were collected electronically via the Qualtrics system. The questionnaires were
graded for accuracy pre-and post-education intervention. The scores were then compared to see
if knowledge was gained from the education module. The data were analyzed to investigate
whether practitioners would contemplate changing their current practice.
Discussion
The questionnaires showed if the educational intervention improved awareness and
knowledge regarding cryotherapy. It also demonstrated how healthcare professionals can impact
the postoperative patient experience and the opioid crisis. Improved knowledge and
understanding can result in increased enthusiasm to use nonopioid pain management modalities
to reduce the number of opioids being consumed in the postoperative setting.
One of the biggest obstacles to the regular use of cryotherapy in the perioperative setting
is the support from perioperative healthcare professionals. Providing education and increasing
knowledge can help trigger support to improve the patient experience and positively impact the
opioid crisis. Improved support was assessed by practitioners claiming to contemplate changing
their practice or a desire to pursue further information regarding the effects of cryotherapy.
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Gaining the support of perioperative healthcare professionals can help guide future perioperative
care toward using nonopioid pain-controlling modalities such as cryotherapy.
Timeline
This project took place over 5 months. Two months were dedicated to developing the
questionnaire and educational intervention. This process included testing the questionnaire,
education module, and data collection while receiving FIU faculty and IRB approval to launch
the project. The education module was then available for access and completion over 1 month.
After this month, an additional 2 months was allotted for data collection, analysis, and project
write-up. After 5 months, it was apparent whether awareness and knowledge were increased
regarding the use of cryotherapy for pain management and if there was increased support for its
use during the perioperative period.
Results
Upon FIU faculty and IRB approval of the questionnaire and education module, the
Qualtrics surveys were sent to the personal e-mails of a predetermined group of FIU CRNA
faculty and alumni. The participants were given 2 weeks to complete the surveys when a
reminder e-mail was sent to the same group of participants. A second reminder e-mail was sent
after another week, and the survey was closed a week later. After 4 weeks of the study being
available, there were 7 total participants. The pretest and posttest surveys were compared for
accuracy to determine if learning occurred in response to the education module (Appendices I, J
and K).
Four of the 7 participants were female, while 3 identified as male. Five participants were
doctoral-prepared CRNAs, while 2 had completed their master's degrees. Years of anesthesia

26
experience were even, with 3 CRNAs practicing for 1-5 years and another 3 practicing for longer
than 10 years. Only 1 participant had between 6-10 years of experience.
Of the 10 total questions included in the pretest and posttest questionnaires, 9 questions
were analyzed for accuracy. One question helped determine if cryotherapy would be used in the
participants’ practice. Of the 9 questions explored, the percentage of correct answers from the
pretest to the posttest increased with 8 questions. The most significant change was 1 question
with 0 correct answers on the pretest to 6 participants answering correctly on the posttest. The
smallest change from pretest to posttest was 1 additional participant responded correctly on the
posttest for 3 of the 8 questions. For 2 of the 8 questions, every participant answered correctly on
the posttest. In an evaluation of the likelihood of participants using cryotherapy in their practice,
3 participants claimed they would be somewhat or extremely likely on the posttest compared to
just 2 on the pretest.
One question had full participation on the pretest, but only 1 participant answered the
question on the posttest. It is unclear whether this question was intentionally or unintentionally
neglected or if a technical issue prevented 6 participants from answering the question. Of the 7
participants who responded to the pretest, only 1 answered correctly. The 1 answer on the
posttest was incorrect, decreasing the number correct on the posttest from the pretest.
Discussion
Of the 9 questions analyzed for accuracy, 8 had an increase in the number of participants
who offered correct answers on the posttest compared to the pretest. Improved scores on the
posttest indicate that learning occurred as a result of the education module. The education
module raised awareness about the extent of the opioid crisis and the use of cryotherapy to
decrease postoperative opioid consumption in orthopedic surgery. Compared to the pretest, the

27
posttest indicated that one additional practitioner would be somewhat or highly likely to utilize
cryotherapy for orthopedic surgery patients. This showed growing support for the use of
cryotherapy. An increased willingness to utilize cryotherapy can help decrease the number of
opioids being used postoperatively, helping curb the opioid crisis and prevent opioid-related
complications.
Strengths of this project included anonymous answers and the ability of CRNAs to
complete the module at their convenience. Healthcare providers’ schedules are not always
conducive to learning at one time and place. The design of this project eliminated that potential
issue. Additionally, the inherent risk of completing the project was no more than any usual work
being performed on a computer, phone, or tablet.
Potential limitations of the project included technical issues that could arise or
participants that clicked through answers without viewing the education module. Similarly, there
was no way to monitor whether participants view the entire education module. This practice
could have affected the conclusions drawn from the results. To minimize limitations, a
participant could not advance to the posttest without beginning the education module; however,
this does not address participants not viewing the entire education module before answering
posttest questions.
Implications for Advanced Nursing Practice
The literature confirms that cryotherapy reduces postoperative opioid consumption in
orthopedic surgery. The results of this project indicate that improved education and increased
awareness regarding cryotherapy will increase the number of practitioners willing to use this
opioid-sparing technique for controlling pain. The fewer opioids necessary for pain control can
decrease the number of opioids patients are being prescribed for postoperative pain. This can
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help reduce addictions and curb the opioid crisis. As a result, cryotherapy could become a
standard nonopioid technique for pain control in orthopedic surgery, allowing advanced nursing
practitioners to help control pain while reducing the number of opioids being prescribed.
Conclusion
The results of this project indicate that learning occurred regarding the effect of
cryotherapy on postoperative opioid consumption in orthopedic surgery. They also suggest an
increase in awareness regarding the use of cryotherapy and an increase in the willingness of
CRNAs to utilize cryotherapy to help control pain. Literature has proven that cryotherapy can
reduce postoperative opioid consumption in orthopedic surgery. Reducing the number of opioids
consumed in the postoperative period can reduce opioid-related complications while adequately
controlling pain. With fewer patients leaving hospitals with opioids, a decrease in addictions
would be expected, helping to curb the lethal opioid crisis that consumes society.
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Appendix A
Literature Review Table

Authors
Brouwers HFG, de
Vries AJ, van
Zuilen M, van
Kouswijk HW,
Brouwer RW. The
role of computerassisted
cryotherapy in the
postoperative
treatment after
total knee
arthroplasty:
positive effects on
pain and opioid
consumption. Knee
Surgery, Sports
Traumatology,
Arthroscopy. 2021.

Purpose
To investigate
whether
cryotherapy is
effective in
reducing
postoperative pain
and postoperative
opioid
consumption
following
orthopedic
surgery.

Method
A singlecenter nonblinded
randomized
controlled
trial.
Level I.

Design
102 patients
were divided
evenly into 2
groups: a
cryotherapy
group and a
control group.
The
intervention
group received
cryotherapy for
the first 7
postoperative
days. Pain and
opioid
consumption
were assessed
daily for the
first 7
postoperative
days. Their pain
was then
assessed at 2
weeks and 6
weeks
postoperatively.

Sample/Setting
Performed in
one hospital.
The sample size
was 102
patients, 51
patients in each
group.

Results
Patients in the
cryotherapy
group had lower
pain scores and
required fewer
opioids
postoperatively
than the control
group during
the first 7
postoperative
days. The
cryotherapy
group required
48% fewer
opioids than the
control group.
At 2 weeks and
6 weeks
postoperatively,
pain was less in
the cryotherapy
group, but not
enough to be
considered
significant.

Conclusions
Cryotherapy
can decrease
pain levels and
opioid
consumption
during the first
postoperative
week following
orthopedic
surgery.
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Kuyucu E, Bülbül
M, Kara A,
Koçyiğit F, Erdil
M. Is cold therapy
really efficient
after knee
arthroplasty?
Annals of Medicine
and Surgery.
2015;4(4):475-478.

To evaluate the
effects of
cryotherapy after
total knee
arthroplasty.

A singlecenter
randomized
controlled
trial.
Level I.

Thijs E, Schotanus
MGM, Bemelmans
YFL, Kort NP.
Reduced opiate
use after total
knee arthroplasty
using computerassisted
cryotherapy. Knee
Surgery, Sports

To investigate the
effect of
cryotherapy on
postoperative pain
and opioid
consumption
following total
knee arthroplasty.

A doubleblind
randomized
controlled
trial.
Level I.

60 patients were
randomly
divided into 2
groups: a
cryotherapy
group and a
control group.
The
experimental
group received
cryotherapy 2
hours
preoperatively,
at 6 hours
postoperatively,
and then for 2
hours daily for
the first 4
postoperative
days. Pain and
analgesia
requirements
were monitored.
60 patients were
randomly
placed into 2
groups: a
cryotherapy
group and a
control group.
The cryotherapy
group received
therapy at 10-12

Performed in
one clinic. The
sample size was
60 patients. 27
patients
received
cryotherapy, 33
patients were in
the control
group.

The total
number of
patients was 60.
There were 2
groups of 30
patients each.

Patients in the
cryotherapy
group reported
lower pain
scores and
required less
analgesia
postoperatively
than the control
group.
Patients also
had higher
scores using
The Knee
Society Scoring
System (KSS),
meaning less
pain, greater
range of
motion, and
greater stability
in the operative
knee.
The cryotherapy
group reported
lower pain
scores than the
control group.
The cryotherapy
group also
consumed
almost 57%
fewer opioids

Cryotherapy
can decrease
pain levels and
the amount of
required
analgesia during
the first 4 days
postoperatively
following total
knee
arthroplasty.

Cryotherapy
lowered pain
scores and
significantly
decreased the
number of
opioids required
postoperatively
compared to the
control group.
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Traumatology,
Arthroscopy.
2019;27(4):12041212.

Chughtai M,
Elmallah RD,
Mistry JB, et al.
Nonpharmacologic
pain management
and muscle
strengthening
following total
knee arthroplasty.
J Knee Surg.
2016;29(03):194200.

To perform a
review of the
current literature
regarding
nonpharmacologic
pain management
following total
knee arthroplasty.

Systematic
literature
review.
Level I.

degrees Celsius
while the
control group
received
therapy at 21
degrees Celsius.
A third party
provided the
therapy to
ensure the
researchers
remained
blinded. Pain
scores and
opioid
consumption
was monitored
for the first 7
postoperative
days.
A literature
search using
PubMed,
EBSCO Host,
and SCOPUS.
Only
manuscripts in
English were
considered. The
search was
performed using
relevant
keywords.

than the control
group
postoperatively.

863 abstracts
were reviewed
with 128 studies
undergoing a
full review. 68
reports were
excluded and 18
more additional
studies were
found from
references. A
total of 52
research articles

3 of the studies
specific to
cryotherapy
found that this
modality
reduces pain
scores and
significantly
reduced
postoperative
opioid
consumption.
The other 3

The authors
concluded that
cryotherapy
reduces pain
levels and
decreases
opioid
consumption
postoperatively.
Additionally,
there seems to
be no extra
benefit between
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were used for
the review.
Specifically, 6
research articles
were used for
review on
cryotherapy.
Ni S-H, Jiang WT, Guo L, et al.
Cryotherapy on
postoperative
rehabilitation of
joint arthroplasty.
Knee Surgery,
Sports
Traumatology,
Arthroscopy.
2015;23(11):33543361.

To review the
literature to
determine the
effectiveness of
cryotherapy
following joint
arthroplasty.

Systematic
literature
review.
Level I.

401 initial
research articles
were found. 371
studies were
excluded for
various reasons.
12 randomized
controlled trials
were used for
this review.

12 randomized
controlled trials
were used for
this review.

studies
compared
different
cryotherapy
modalities and
found no
significant
differences.
It was shown
that cryotherapy
reduced pain
scores and
decreased
opioid
consumption on
postop day 2. It
showed no
difference on
the first
postoperative
day.

different
cryotherapy
modalities.
However, that is
beyond the
scope of this
review.
Cryotherapy is
effective at
reducing pain
scores and
decreasing the
number of
opioids required
on
postoperative
day 2.
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Appendix B
Faculty Support Letter

February 2, 2022
Valerie Diaz DNP, CRNA, APRN Clinical
Assistant Professor
Department of Nurse Anesthesiology
Florida International University
Dear Dr. Diaz,
I thank you inquiring on the use of the FIU DNAP alumni list for participation in the Doctor of Nursing Practice
(DNP) project conducted by Cody Wilson a entitled “An Educational Module Explaining the Effect of
Cryotherapy on Postoperative Opioid Consumption in Orthopedic Surgery: A Quality Improvement Project” in the
Nicole Wertheim College of Nursing and Health Sciences, Department of Nurse Anesthetist Practice at Florida
International University. I have granted Mr. Wilson permission to conduct the project using our providers.
Evidence-based practice's primary aim is to yield the best outcomes for patients by selecting interventions supported
by the evidence. This project intends to evaluate if a structured education targeting anesthesia providers will increase
knowledge on the use Effect of Cryotherapy on Postoperative Opioid Consumption in Orthopedic Surgery.
We understand that participation in the study is voluntary and carries no overt risk. All Alumni Anesthesiology
providers are free to participate or withdraw from the study at any time. The educational intervention will be
conveyed by a 15-minute virtual PowerPoint presentation, with a pretest and posttest questionnaire delivered by a
URL link electronically via Qualtrics, an online survey product. Responses to pretest and posttest surveys are not
linked to any participant. The collected information is reported as an aggregate, and there is no monetary
compensation for participation. All collected material will be kept confidential, stored in a password encrypted
digital cloud, and only be accessible to the investigators of this study: Cody Wilson and Dr. Diaz.
Once the Institutional Review Board's approval is achieved, this scholarly project's execution will occur over two
weeks. Cody Wilson will behave professionally, follow standards of care. We support the participation of our
Anesthesiology providers in this project and look forward to working with you.

Sincerely,

Jorge A. Valdes, DNP, CRNA, APRN
Interim Chair, Department of Nurse Anesthesiology
Associate Professor
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Printed By: Wilson, Cody
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Report Comments

Protocol Information

Version # 1

Reference Number: 111411
Protocol Number: IRB-22-0139
Protocol Title: An Educational Module Explaining the Effect of Cryotherapy on Postoperative Opioid Consumption in
Orthopedic Surgery: A Quality Improvement Project
Protocol Type: Original
Principal Investigator: Diaz, Valerie

Approval Date: 4/4/2022

Submittal Date: 4/4/2022

Effective Date: 4/7/2022

Author: Wilson, Cody

Renewal Date: 4/4/2027

Status: Approved

Next Review Date: 4/4/2027

Inactive Date:

Expiration Date: 4/4/2027

INSTRUCTIONS

1
1.1

Completing this IRB Exemption Form

This IRB Exemption Form is used for obtaining approval for exempt human subject research.
While filling out this form, some questions may have additional information in the blue "?" help icon located on the right of the question.
For additional assistance with completing this form, visit the Office of Research Integrity Topaz website located at:
http://research.fiu.edu/irb/pages/topaz.html
Save often by selecting the "Save" icon at the top of this form since the system does not automatically save your progress.

***********************************************
FORM TEMPLATE COMPLIES WITH REVISED COMMON RULE
***********************************************
This IRB Exemption Form template complies with the new IRB regulatory requirements (Revised Common Rule), which went into effect on January
21, 2019.
IMPORTANT: The Department of Justice (DOJ) has not signed onto the Revised Common Rule. If this study will be funded by a DOJ agency, then
you cannot use this IRB Exemption Form template. Please contact Chris Grayson at 305-348-8379 or graysonc@fiu.edu to get special access to a
different version of the IRB Exemption Form that is based on the Old Common Rule requirements.
ADMINISTRATIVE

2

Reference Number

2.1

This number is system generated.

111411
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2.2

Protocol Number

This number will be assigned after the protocol has been processed.

IRB-22-0139
2.3

Relation to Another FIU IRB Approved Study

Is this a sub-study, which is based off of a larger study (e.g., this study utilizes the data or participants from a larger study)?
Yes
No
Yes

2.3.1

No

2.3.2

Title

2.4

Provide the title of the project.

An Educational Module Explaining the Effect of Cryotherapy on Postoperative Opioid Consumption in Orthopedic Surgery: A
Quality Improvement Project
Department

2.5

Select the FIU Principal Investigator's department.

CNHS Nursing Anesthesia
Principal Investigator

2.6

Provide the name of the FIU Principal Investigator (PI).
Students cannot serve as the PI. Courtesy and voluntary faculty members cannot serve as the PI.
Please Note: Undergraduate/Graduate student research projects are required to have an FIU faculty member with Graduate Faculty Status or
Dissertation Advisor Status (DAS) serving as the Principal Investigator. Student researchers need to be listed separately in the "Protocol Associates"
section below. Exceptions to this policy may be judged appropriate under particular circumstances and those exceptions shall be determined by the
Office of Research and Economic Development.
Diaz, Valerie

vdiaz@fiu.edu

ext
2.7

Author

The Author is the person that is completing this application form. This is typically the same person as the Principal Investigator unless another
individual is assisting with the completion of the application form (e.g., Project Coordinator).
The Author will be able to access and edit the initial submission as well as all future amendments, renewals, and interim submissions that are
associated with this project.
Wilson, Cody

cwils089@fiu.edu
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2.8

Protocol Associates

Add all FIU Co-Investigators and FIU Key Associates that will be engaged in this project. Individuals are considered "engaged" if they will be
intervening or interacting with human subjects (e.g., consenting subjects, collecting data, etc) and/or accessing coded or identifiable human subject
data (e.g., data analysis). See the OHRP Engagement Guidance or contact the FIU IRB Office (ORI) for more information on whether someone is
considered engaged.
Individuals that are designated as Co-Investigators can view and edit this application and will also receive email alerts.
Individuals that are designated as Key Associates cannot view and edit this application, but will receive certain email alerts.
Select the green "+" icon to the right to add the individual(s). Select only one role per person. List the responsibilities for each individual.
Wilson, Cody
Responsibilities

Recruiting subjects, consenting subjects, collecting data, administering pre/post-test, data analysis

Comments
Co-Investigator

Key Associate
2.9

Protocol Associates (Not Requiring TOPAZ Access)

Add all FIU Co-Investigators and FIU Key Associates that will be engaged in this project, but do not need the ability to view/edit the protocol or
receive TOPAZ system email notices regarding this protocol.
For the "Role" column, designate if the individual is a Co-PI or Key Associate on the project. For the "Position" column, designate if the individual
is a Faculty Member, Staff Member, Undergrad Student, Grad Student, or Post-Doc. "Responsibilities" might include data entry, recruiting subjects,
consenting subjects, etc. Click "Add Row" to add each individual.
See the OHRP Engagement Guidance or contact the FIU IRB Office (ORI) for more information on whether someone is considered engaged.
First Name

Last Name

Role

Position

Department

Email

Panther ID

Responsibilities

2.10

External Protocol Associates

Indicate if there will be any external (non-FIU) Co-Investigators or Key Associates engaged in this project. Individuals are considered "engaged" if
they will be intervening or interacting with human subjects (e.g., consenting subjects, collecting data, etc) and/or accessing coded or identifiable
human subject data (e.g., data analysis). See the OHRP Engagement Guidance or contact the FIU IRB Office (ORI) for more information on whether
someone is considered engaged.
Yes
No
Yes

2.10.1

No

2.10.2
2.11

IRB Educational Training (Attachment)
Attachments: Diaz CITI Training Certificate.pdf,Cody CITI Training Certificate.pdf

All investigators and key personnel that are engaged in conducting research with human subjects are required to complete the web-based
Collaborative Institutional Training Initiative Program (CITI) training in the protection of human research subjects. Indicate below if all of the
individuals on this project have completed the required CITI IRB training. See the IRB Training web page for more information.
Attach the CITI IRB Training Completion Reports. Click the paper clip icon to the right to upload the documents.
Yes - CITI IRB Training has been completed by all project personnel.
No - CITI IRB Training has not yet been completed by all project personnel.
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Yes - CITI IRB Training has been completed by all project personnel.

2.11.1

No - CITI IRB Training has not yet been completed by all project personnel.

2.11.2
2.12

Good Clinical Program (GCP) Training (Attachment)

All researchers that are engaged in conducting one of the following types of research studies are also required to complete online GCP training:

1.

NIH funded clinical trial (one or more human subjects are prospectively assigned to one or more interventions, which may include placebo or

other control, to evaluate the effects of those interventions on health related biomedical or behavioral outcomes); or

2.

FDA regulated clinical trial (involving drugs, devices, or biologics)

Indicate the type of project that you are conducting below. See the IRB Training web page for more information.
Attach the GCP Training Completion Reports if this study is an NIH or FDA Clinical Trial. Click the paper clip icon to the right to upload the
documents.
Clinical Trial (NIH Funding)
Clinical Trial (FDA Regulated - Drugs, Devices, or Biologics)
Clinical Trial (No NIH Funding and not FDA Regulated)
Not Applicable (Not a Clinical Trial)
Clinical Trial (NIH Funding)

2.12.1

Clinical Trial (FDA Regulated - Drugs, Devices, or Biologics)

2.12.2

Clinical Trial (No NIH Funding and not FDA Regulated)

2.12.3

Not Applicable (Not a Clinical Trial)

2.12.4
2.13

Conflict of Interest

Does anyone on this study team, their spouses, or dependent children have a financial interest (including salary or other payments for services,
equity interests, or intellectual property rights) that would reasonably appear to be affected by the research, or a financial interest in any entity whose
financial interest would reasonably appear to be affected by the research?
Yes
No
Yes

2.13.1

No

2.13.2

EXEMPTION REVIEW TYPE

3
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3.1

Exemption Category Number

Indicate the Exemption Category Number(s) that you feel would be appropriate for this protocol. The most commonly used categories are Categories
#1, #2, and #4. Final determination will be made by the Office of Research Integrity.
Note: The detailed Exempt Review Categories Listing is available on the FIU IRB website.
Exemption Category #1 (Educational Practices Research in an Educational Setting)
Exemption Category #2 (Educational Tests, Survey Procedures, Interview Procedures or Observation of Public Behavior)
Exemption Category #3 (Benign Behavioral Interventions)
Exemption Category #4 (Secondary Research for which Consent is not Required)
Exemption Category #5 (Research and Demonstration Projects with Department or Agency Heads that Study Public Benefit or Service Programs)
Exemption Category #6 (Taste and Food Qualify Evaluation and Consumer Acceptance Studies)
3.1.1

Exemption Category #1 (Educational Practices Research in an Educational Setting)

3.1.2

Exemption Category #2 (Educational Tests, Survey Procedures, Interview Procedures or Observation of Public Behavior)

3.1.2.1

Exemption #2: Educational Tests, Surveys, Interviews, and Observations

Research that only includes interactions involving educational tests (cognitive, diagnostic. aptitude, achievement), survey procedures, interview
procedures or observation of public behavior (including visual or auditory recording).
3.1.2.2

Exemption #2: Use of Children in Surveys or Interviews

For research proposed under this category, will the research involve surveys or interview procedures with children?
eligible for this Exemption category.

If yes, your research will not be

Yes
No
Yes

3.1.2.2.1

No

3.1.2.2.2
3.1.2.3

Exemption #2: Use of Children in Observations

For research proposed under this category, will the research involve observations of the public behavior of children, during which an investigator
participats in the activities being observed? If yes, your research will not be eligible for this Exemption category.
Yes
No
Yes

3.1.2.3.1

No

3.1.2.3.2
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3.1.2.4

Exemption #2: Information Obtained

For research proposed under this category, one or more of the following criteria will need to be selected in order to be considered for Exemption #2.
Select "2.1" if you will be collecting anonymous data.
Select "2.2" if you will be collecting identifiable (or coded) "non-sensitive" data .
Select "2.3" if you will be collecting identifiable (or coded) "sensitive" data .
Sensitive data are considered as data that could potentially put the subjects at risk of criminal or civil liability or be damaging to the subject's
financial standing, employability, educational advancement, or reputation.
2.1 - The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained,
directly or through identifiers linked to the subjects
2.2 - Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or
be damaging to the subject's financial standing, employability, educational advancement, or reputation
2.3 - The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained,
directly or through identifiers linked to the subjects (requires Limited IRB Review)
3.1.2.4.1
2.1 - The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained,
directly or through identifiers linked to the subjects
3.1.2.4.2
2.2 - Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability
or
be damaging to the subject's financial standing, employability, educational advancement, or reputation

2.3 - The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained,3.1.2.4.3
directly or through identifiers linked to the subjects (requires Limited IRB Review)
Exemption Category #3 (Benign Behavioral Interventions)

3.1.3

Exemption Category #4 (Secondary Research for which Consent is not Required)

3.1.4

Exemption Category #5 (Research and Demonstration Projects with Department or Agency Heads that Study Public Benefit or Service Programs) 3.1.5
Exemption Category #6 (Taste and Food Qualify Evaluation and Consumer Acceptance Studies)
EXEMPTION REQUIREMENTS

3.1.6
4
4.1

Minimal Risks

Will the research expose participants to discomfort or distress beyond that normally encountered in daily life? If yes, your research will not be
eligible for Exempt review.
Yes
No
Yes

4.1.1

No

4.1.2

Protected Health Information (PHI)

4.2

Will you be accessing or using identifiable protected health information (PHI) from medical records (other than the use of a limited dataset)? If yes,
your research will not be eligible for Exempt review.
Note: Studies that involve the access or use of PHI through authorization forms or requests for waivers/alteration of authorization are not eligible for
Exempt Review.
For more information, visit the Privacy Practices and HIPAA web page.
Yes
No
4.2.1

Yes
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4.2.2

No

4.3

Prisoners

Will prisoners (or their data and/or specimens) be participants and examined as a subpopulation in this research study? If yes, your research will not
be eligible for Exempt review.
Yes
No
Yes

4.3.1

No

4.3.2
4.4

Deception

Will this study involve deception (i.e., providing false or incomplete information to participants for the purposes of misleading research subjects)?
yes, your research will not be eligible for Exempt review.

If

Yes
No
Yes

4.4.1

No

4.4.2
4.5

FDA Regulations

For research proposed under Exemption Categories 1-5, is the research subject to FDA regulations?
Exempt review.

If yes, your research will not be eligible for

Yes
No
Yes

4.5.1

No

4.5.2

PROJECT OVERVIEW

5
5.1

Project Starting Date

Provide the date that you are planning to begin the research with human subjects (e.g., date to begin recruitment or access a database). Click the
calendar icon below to select your starting date.
Please use a future starting date.

Sunday, May 1, 2022 12:00 AM
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5.2

Project Completion Date

Provide the date that you are planning to finish the research with human subjects (e.g., date that you will be finished with all data analysis). Click the
calendar icon below to select your completion date.

Saturday, October 1, 2022 12:00 AM
Funding

5.3

Indicate if funding is (or will be) associated with this project.
Yes
No
Yes

5.3.1

No

5.3.2
5.4

Student Research Project

Is this study being conducted in relation to an undergraduate or graduate research project?
Please answer yes to this question if one of the following apply :

1.
2.

This protocol submission is for a student research project; or
This protocol submission is for a faculty research project, but a student researcher will be conducting a sub-study using coded or identifiable

data from this main faculty research project.
Yes
No
5.4.1

Yes

5.4.1.1

Relation of Student Research Project

Please select how this protocol submission is related to a student research project.
This protocol submission is for a student research project
This protocol submission is for a faculty research project, but a student will be conducting a sub-study with data from the faculty research project
5.4.1.1.1

This protocol submission is for a student research project

This protocol submission is for a faculty research project, but a student will be conducting a sub-study with data from the faculty research project 5.4.1.1.2
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5.4.1.2

Type of Student Project (Attachment)

Select the type of student project that this study falls under.
Attach a copy of the five page UGS proposal if the study is part of a Thesis or Dissertation. Click the paper clip icon to the right to upload your
document.
Graduate Research
A study being conducted by a graduate student, but not part of a Thesis or Dissertation.

5.4.1.3

Student Investigator Details

Provide the following details about the primary student investigator that will be conducting the student research project.
First Name

Last Name

Email Address

Cody

Wilson

cwils089@fiu.edu

Phone Number
614-937-6796

Panther ID
1936909
5.4.2

No
Type of Project

5.5

Indicate the type of project you will be conducting by selecting the green "+" icon on the right. Select all that apply for this project.
5.5.1

Data Collection Study
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5.8.1.2

Domestic Site Details
Attachments: Letter of Support.pdf

Provide the details below for each site/location that will be used in the research study. Examples of tasks done at a site might include activities such
as recruitment, consenting, data collection, etc.
Note: If the research will take place at FIU, then please list FIU and the Building and Room Number in the Address column (e.g., FIU MARC 430).
Click "add row" for each additional site that you need to add.
Location Name

Address

City

State

Florida International
University

11200 SW 8th St.

Miami

FL

Phone Number

Task(s) Done at Site
None. All recruitment,
consenting, educational
intervention, pre- and
post-testing, and data
analysis will be done
virtually. "NO DATA
ANALYSIS WILL BE
DONE AT FIU"
5.8.2

International Site (Foreign)
SUBJECT POPULATION

6

Duration of Participation

6.1

Estimate the time required from each participant, including individual interactions, total time commitment, and long-term follow-up, if any.

Participation is expected to span a total of approximately 2 months. The online pre-test and post-test are expected to take 20
minutes. Pre-test 5 minutes, post-test 5 minutes, and educational session 10 minutes.
Number of Participants

6.2

The number of participants is defined as the number of individuals who agree to participate even if all do not prove eligible to complete the study. If
datasets are being used, then provide the number of datasets that will be accessed.

Approximately 10.
Gender of Subjects

6.3

Indicate the gender of the subjects.
Both
6.4

Age of Subjects

Select the age range(s) of the subjects. Click the green "+" symbol to the right of the screen to make your selection(s). Select all that apply.
25-59 Years

6.4.1

60+ Years

6.4.2
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6.5

Participant Populations

Specify the participant population(s) to be included. Click the green "+" symbol to the right of the screen to select the populations. Select all that
apply.
6.5.1

Adults

6.6

Other Populations

If you chose "Other" in the previous question, please indicate the other population below. Otherwise, put "N/A" for your response.

N/A
SUBJECT RECRUITMENT

7

Identification of Subjects

7.1

Describe how potential participants will be identified (e.g., individuals known to investigator, record review, etc.). Explain how investigator(s) will
gain access to this population, as applicable.

Potential participants will be identified via personal email retrieved from an email list supplied by the chair of the department
of Nurse Anesthesiology at Florida International University.
The alumni email addresses are the personal commercial emails, not FIU emails, that FIU graduates voluntarily supplied
after graduating from the university. Such emails are not the property of FIU and FIU records are not being accessed by the
PI and Co-Pi. FERPA regulations are maintained. The email addresses are not linked to names or any personal identifier so
that participant anonymity is maintained.
7.2

Recruitment/Advertising Process (Attachment)
Attachments: Recruitment Letter.pdf

Describe the recruitment process; including the setting in which recruitment will take place. Describe the types of advertisements that will be used
(e.g., ads, flyers, website postings, recruitment letters, and/or oral written scripts). Explain how the process respects potential participants' privacy.
Attach copies of the proposed recruitment materials. Click the paper clip icon to the right to upload your document(s).

Recruitment Letter will be distributed via personal email where potential participants are blind copied to maintain privacy.
See letter attached here.
Participation is anonymous and data are reported as a group. Responses to online pre-test and post-test surveys may not be
linked to any participant. In this way, all participants' privacy is maintained.
All pre-test and post-test surveys will be delivered via Qualtrics, an Online survey product for which the URL link is provided.
Collected data will be maintained on the Qualtrics secure website under password protection. Data will only be accessible to
the investigators in this study: Dr. Valerie Diaz and Cody Wilson.
The alumni email addresses are the personal commercial emails, not FIU emails, that FIU graduates voluntarily supplied
after graduating from the university. Such emails are not the property of FIU and FIU records are not being accessed by the
PI and Co-Pi. FERPA regulations are maintained. The email addresses are not linked to names or any personal identifier so
that participant anonymity is maintained.
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7.3

Participant Compensation or Incentives

Indicate if participants will receive compensation or other incentives to participate in the research study.
Yes
No
Yes

7.3.1

No

7.3.2

METHODS & ACTIVITIES

8
8.1

Explanation of Methods & Activities (Attachment)
Attachments: Questionnaire Edited.pdf,DNP Edu PPT.pdf

Identify and describe all interactions that are to be performed solely for the research study. Explain the methods and procedures to be followed with
an emphasis on implications for subjects' experiences. Describe data to be collected. List the names of the different data collection forms that you
will be using if conducting surveys, interviews, and/or focus groups.
Attach data collection forms to be used by clicking on the paper clip icon to the right.

With their consent, participants will complete an anonymous online pre-test survey to assess their knowledge, perceptions,
and current clinical practices regarding the effect of cryotherapy on postoperative opioid consumption in orthopedic surgery.
The survey is to be completed individually and is expected to take up to 5 minutes to complete. Then, the participants will
complete an online educational PowerPoint based on the results of a related literature review. Participants will be asked to
complete the post-test, which will be identical to the pre-test. The online post-test survey is expected to take up to 5 minutes
to complete. The PowerPoint is attached here.
Participants will be asked to complete the post test, which mirrors the pretest. The post test survey is expected to take up to
five minutes to complete.
Data will be collected using the pre-test/post-test survey form attached. No identifiable private information is to be collected.
Demographic data, including gender, age, level of education, and years of experience will be obtained as part of the survey.
Additionally, the online pre-test/post-test survey will be used to collect data related to participants' knowledge, perceptions,
and practices related to cryotherapy and postoperative opioid consumption in orthopedic surgery. NO DATA ANALYSIS WILL
BE DONE AT FIU. ALL DATA ANALYSIS WILL BE COMPLETED VIRTUALLY. NO FACE TO FACE OR IN PERSON
ACTIVITIES WILL TAKE PLACE.
8.2

Types of Activities

Carefully identify all of the activities that will be involved in the research by clicking on the green "+" icon to the right. Identify ALL that apply to
the research.
Internet or Email Data Collection

8.2.1

Surveys or Interviews (Individual)

8.2.2
8.3

Use of Secondary Data/Specimens

Indicate below if this study will involve the use of pre-existing secondary data or secondary specimens.
Yes
No
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Yes

8.3.1

No

8.3.2
8.4

Miscellaneous or Additional Information

This area can be used to incorporate any additional information or attachments that pertain to this study (i.e., information or attachments that do not
pertain to any of the other questions above).

None
BENEFITS & RISKS

9

Benefits to Subjects

9.1

List the potential benefits that participants may expect as a result of this research study. State if there are no direct benefits to individual participants.
Compensation is not to be considered a benefit.

Potential benefits to participants include improved knowledge of the effect of cryotherapy on postoperative opioid
consumption in orthopedic surgery.
9.2

Benefits to Society and/or Others

List the potential benefits that society and/or others may expect as a result of this research study.

It is expected that this study will benefit society by guiding practitioners to using cryotherapy to decrease postoperative
opioid consumption in orthopedic surgery.
9.3

Risks, Harms, and/or Discomforts

Justify why this project involves no more than minimal risk. Consider the range of risks, including physical, psychological, social, legal, and
economic.

The probability and magnitude of risk, harm, or discomfort anticipated in research are not greater in and of themselves than
those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests
and is therefore considered minimal.
INFORMED CONSENT

10
10.1

Informed Consent in Exempt Research

The use of informed consent is not required and its use is optional for "exempt" research projects (unless the study involves deception). It is
"suggested" for exempt research projects to utilize an "informational letter" ( an informational letter provides the subjects with a brief overview of the
study, but it does not require the subject to provide their informed consent to participate ). However, the use of an informational letter is also optional
(unless specifically requested by the IRB). Investigators have the option of deciding if they would like to utilize either of these documents in their
exempt studies.
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10.2

Informed Consent or Informational Letter

Will you be utilizing an informed consent document or an informational letter for this study?
Note: If the study involves deception, you will need to answer "yes" to this question.
Yes
No
10.2.1

Yes

10.2.1.1

Explanation of Consent Procedures (Attachment)
Attachments: Consent revised.pdf

Indicate the consent process and document(s) that will be used in the study. See Consent for Research for guidelines and sample templates.
Attach copies of your Informed Consent Form (or Informational Letter) by clicking on the paper clip icon to your right.

PROCEDURES
If you agree to be in the project, we will ask you to do the following things:
1. Complete an online 10 question pre-test survey via Qualtrics, an Online survey product for which the URL link is provided.
2. Review the educational PowerPoint Module lasting 10 minutes via Qualtrics, an Online survey product for which the URL
link is provided.
3. Complete the online 10 question post-test survey via Qualtrics, an Online survey product for which the URL link is
provided.
RISKS AND/OR DISCOMFORTS
The main risk or discomfort from this research is minimal. There will be minimal risks involved with this project, as would be
expected in any type of educational intervention, which may have included mild emotional stress or mild physical discomfort
from sitting on a chair for an extended period of time, for instance. However, if participant becomes fatigued, he may opt out.
BENEFITS
The following benefits may be associated with your participation in this project: An increased understanding on the effect of
cryotherapy on postoperative opioid consumption in orthopedic surgery.
The overall objective of the program is to increase the quality of healthcare delivery and improve healthcare outcomes for
our patients.
ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project. However, if you would like to
receive the educational material given to the participants in this project, it will be provided to you at no cost.
CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent provided by law. If, in any sort of
report, we might publish, we will not include any information that will make it possible to identify you as a participant.
Records will be stored securely, and only the project team will have access to the records.COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or for participating in this project.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or withdraw your consent at any time
during the project. Your withdrawal or lack of participation will not affect any benefits to which you are otherwise entitled.
The investigator reserves the right to remove you without your consent at such time that they feel it is in the best interest.
Participant is provided the opportunity to accept or decline when prompted by the survey software after reading the consent
letter.
10.2.2

No
CONFIDENTIALITY & PRIVACY

11
11.1

Information on Confidentiality and Privacy

Please review the IRB Data Management Security Tips for a listing of the best practices for securing data. Click the blue "?" icon to the right to learn
about the differences between confidentiality and privacy.
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11.2

Data Storage Methods

Select the different methods that will be used for storing your data. Please select the green "+" icon to the right to make your selections. Select all
that apply.
Laptop Computer

11.2.1

Survey Website Database

11.2.2
11.3

Provisions to Protect Privacy

Describe the provisions to protect the privacy interests of the participants.

All data regarding participant knowledge, perceptions, and practices regarding cryotherapy and postoperative opioid
consumption in orthopedic surgery will be collected anonymously. Only investigators will have access to the information
collected.
FERPA Student Education Records

11.4

Researchers are required to follow the Family Educational Rights and Privacy Act (FERPA) requirements when accessing, using or disclosing FIU
student education records for research purposes.
For more information, visit the FIU Student Education Records (FERPA) web page . In addition, you can view the regulatory requirements at 34
CFR Part 99.
Will individually identifiable FIU student education records be accessed, used, or disclosed in this research study?
Yes
No
Yes

11.4.1

No

11.4.2
11.5

Associating a Participant to a Study

You should select "Yes" to this question if it will be possible for you to associate a participant to your study (e.g., via a name on a signed consent
form, via a name in the Sona System, etc.).
You should select "No" to this question if it will not be possible for you to associate a participant to your study (e.g., the names of subjects are never
collected or provided to the researchers).
Yes - It will be possible for me to associate a participant to my study
No - It will not be possible for me to associate a participant to my study
Yes - It will be possible for me to associate a participant to my study

11.5.1

No - It will not be possible for me to associate a participant to my study

11.5.2
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11.6

Associating Data to an Individual

Does the research require the access or collection of personally identifiable data about human subjects?
Personally identifiable data are considered data about a human that can be associated to a subject through one of the following methods:

1.
2.

Direct identifier (i.e., name, birthdate, social security number, medical record number, mailing address, etc.) or
Indirect identifier (i.e., a unique code that links the data back to the subject via a master key).

Note: You will need to mark "yes" if you will be working with coded data (regardless of whether you will have access to the master key).
Yes - I will be accessing or collecting "personally identifiable data" (or "coded data")
No - I will only be accessing or collecting "anonymous data" (not possible for anyone to link back to a subject)
Yes - I will be accessing or collecting "personally identifiable data" (or "coded data")
No - I will only be accessing or collecting "anonymous data" (not possible for anyone to link back to a subject)

11.6.1
11.6.2
11.6.2.1

Explanation of Anonymous Data

Describe the variables that will be collected for your study. Provide an explanation as to how the study will be conducted such that it will not be
possible to link the data back to the subjects at any point during or after the study.

Participation takes place via a URL link generated by Qualtrics, a web-based platform and is therefore anonymous. There is
no identifiable private information collected. Collected data only includes responses to the survey questions regarding the
education module. No survey questions ask for responses that can provide identifiable information about participants. The
URL link will be distributed via email where potential participants are BLIND copied to protect privacy (bcc email only). The
measured variable is knowledge base. Responses correspond to the education module distributed to all participants.
Responses are multiple choice items, no free text responses. The measurement is provider's knowledge of the effect of
cryotherapy on postoperative opioid consumption in orthopedic surgery.
A unique identifier is assigned by Qualtrics to the participant which links the pre and the post test data
Confidentiality of Data

11.7

Explain how information is handled, including storage, security measures (as necessary), and who will have access to the information. Be sure to
address both the electronic and hard copy versions of your records in your explanation.

All data will be collected anonymously. No identifiable private information will be collected as part of the online pre-test and
post-test surveys. Only investigators will have access to the completed pre-test and post-test surveys. There will be no hard
copy forms. Data collected from the online pre-test and post-test surveys will be tabulated anonymously to electronic
spreadsheets, which will be maintained on a password protected laptop computer.
11.8

Data Protection Methods

Select the different security methods that will be used for protecting your stored data. Please select the green "+" icon to the right to make your
selections. Select all that apply.
11.8.1

Password Protection

Persons reviewing the information contained herein are reminded of their confidentiality obligations pursuant to the FIU Confidentiality Agreements Policy #1710.070.
Page 17 of 20

55

Protocol Detail Report

Printed By: Wilson, Cody
4/8/2022 4:57:51 PM
11.9

Location of Data

Provide the physical location(s) where the data will be stored (e.g., provide the campus, building, and office room number). If data will not be
physically stored anywhere (e.g., it will only be stored on a network, website, SharePoint, etc), then please indicate this below.

Only anonymous data will be collected. This anonymous data will be stored on a password protected laptop.
Transportation of Data

11.10

Indicate if data will need to be transported (physically or electronically).
Yes, data will need to be physically or electronically transported
No, data will not need to be physically or electronically transported
Yes, data will need to be physically or electronically transported

11.10.1
11.10.1.1

Procedures for Securing the Data

Indicate how you will secure the data during physical and/or electronic transport to minimize the risks of data loss. Indicate the steps that will be
taken to minimize the duration of the transit.

Electronic data will be maintained under password protection to which access will be limited to the PI, Co-PI.
No, data will not need to be physically or electronically transported
Breaking Confidentiality

11.10.2
11.11

Explain any circumstances (ethical or legal) where it would be necessary to break confidentiality.

There are no foreseeable circumstances in which it would be necessary to break confidentiality.
AFFIRMATION OF COMPLIANCE

12
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13.1

Office Use Only

The FIU Office of Research Integrity will use this remaining "Office Use Only" section for administrative purposes after the protocol has received its
exemption determination. The investigator does not need to complete anything within this section.
13.2

IRB Exemption Memorandum
Attachments: Initial Approval

The FIU Office of Research Integrity will use this area to attach a PDF copy of the most recent IRB exemption memorandum.
13.3

IRB Approval Type

The FIU Office of Research Integrity will use this area to display the approval type that was used for the initial review (i.e., Exempt).
Note: This approval type designation will remain the same for all subsequent amendments.
Exempt Determination
IRB Exemption Category

13.4

The FIU Office of Research Integrity will use this area to display the final determined exemption category number(s).
13.4.1

Category 2

13.5

Additional IRB Approval Details

The FIU Office of Research Integrity will use this area to reference any additional details that pertain to this approved project.
IRB Authorization Agreement (IAA)
Individual Investigator Agreement (IIA)

IRB Authorization Agreement (IAA)

13.5.1

Individual Investigator Agreement (IIA)

13.5.2
13.6

Other Notes

The FIU Office of Research Integrity will use this area to record any additional notes regarding the project.

Persons reviewing the information contained herein are reminded of their confidentiality obligations pursuant to the FIU Confidentiality Agreements Policy #1710.070.
Page 20 of 20

58
Appendix E
Participant Recruitment Letter

An Educational Module Explaining the Effect of Cryotherapy on Postoperative Opioid
Consumption in Orthopedic Surgery: A Quality Improvement Project
Dear FIU Alumni CRNA:
My name is Cody Wilson and I am a student from the Anesthesiology Nursing Program
Department of Nurse Anesthetist Practice at Florida International University. I am writing to
invite you to participate in my quality improvement project. The goal of this project is to
improve health care provider knowledge on the effect of cryotherapy on postoperative opioid
consumption in orthopedic surgery. You are eligible to take part in this project because you are
an FIU alumni CRNA.
If you decide to participate in this project, you will be asked to complete a consent form for
participation. Next, you will complete a pretest questionnaire, which is expected to take
approximately 5 minutes. You will then be asked to view an approximately 15 minute long
educational presentation online. After watching the video, you will be asked to complete the
posttest questionnaire, which is expected to take approximately 5 minutes. No compensation will
be provided.
Remember, this is completely voluntary. You can choose to be in the study or not. If you'd like
to participate or have any questions about the study, please email or contact me at
cwils089@fiu.edu or 614-937-6796.
Follow this link to the Survey:
Take the Survey
Or copy and paste the URL below into your internet browser.
https://fiu.qualtrics.com/jfe/form/SV_efFTrAHqfqggorY
Thank you very much.
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Sincerely,
Cody Wilson, RN, BSN, SRNA
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Appendix F
Participant Consent
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Appendix G
Pretest and Posttest Questionnaire

Pretest and Posttest Questionnaire: An Educational Module Explaining the Effect of
Cryotherapy on Postoperative Opioid Consumption in Orthopedic Surgery: A Quality
Improvement Project
PERSONAL INFORMATION (Optional)
1. Gender: Male

Female

2. Age: ______
3. Level of Education:

Masters

Doctoral (DNP, DNAP, EdD, PhD)

4. Years of Experience: Less than 1 year

1 to 5 years

6 to 10 years

More than 10 years

QUESTIONNAIRE
1. Which of these factors contributes to the complexity of modern day pain management?
A. Undertreated pain goes away spontaneously
B. Higher survival rates from illnesses and traumas
C. Lower pain tolerances
D. Increased frequency and simpler surgical procedures
2. Each time a patient refills an opioid prescription after surgery, the rate of opioid misuse
increases by:
A. 10%
B. 23%
C. 44%
D. Number of refills have no effect
3. The United States is responsible for what percentage of the world’s opioid use?
A. 50%
B. 80%
C. 30%
D. 70%
4. The majority of opioid abusers began their addictions from:
A. Prescription medications
B. Psychiatric instability
C. Taking extra medications from family and friends
D. The need to find an escape
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5. The procedures with the highest postoperative opioid consumption are (select 2):
A. Total knee arthroplasty
B. Laparoscopic cholecystectomy
C. Posterior lumbar fusion
D. Total hip arthroplasty
6. Opioid-related complications that occur post-operatively have been shown to increase the
risk of hospital admission by what percentage?
A. 22%
B. 30%
C. 40%
D. 54%
7. Which of these is believed to be one physiologic mechanism that accounts for the
effectiveness of cryotherapy in limiting pain?
A. Decreased temperature inactivates mu receptors.
B. Increased body temperature helps to fight postoperative infections.
C. Slowed nerve conduction velocity decreases stimulation to the brain.
D. Cryotherapy temporarily immobilizes the joint, reducing pain.
8. The cooling of synovial fluid is believed to have what direct effect on limiting pain?
A. Decreased swelling
B. Decreased nerve conduction
C. Decreased fluid shifts
D. Decreased prostaglandin
9. In randomized control trials, cryotherapy has been shown to reduce postoperative opioid
consumption by as much as:
A. 24%
B. 48%
C. 57%
D. 72%
10. How likely are you to consider using cryotherapy for postoperative pain management in
your anesthetic plan for orthopedic surgery cases?
A. Not likely
B. Somewhat likely
C. Likely
D. Very likely
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Appendix H
Education Module

6/26/22

An Educational M odule Explaining
the Effect of Cryotherapy on
Postoperative Opioid Consum ption in
Orthopedic Surgery: A Quality
Im provem ent Project
Cody Wilson
Florida International University

1

Learning Goals

1
Increase awareness of cryotherapy

Improve education on cryotherapy
Gain support for the use of cryotherapy in the postoperative
period

2

Com plexity of Pain M anagem ent 1
Undertreated acute pain becomes chronic

Aging population

Higher survival rates from illnesses and trauma

Increased frequency and complexity of surgery

3
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Opioids 1,2,3
-Fast-acting
-Powerful pain relief
-Induce hypnotic states
-Blunt hemodynamic
responses to surgical
stress

-Repeated use
suppresses endogenous
opioids, leading to
dependence, tolerance,
and addiction
-Acts on mu-opioid
receptors, which
control breathing

4

T h e O p io id C risis
Drug Overdose Death Rates in the United States from 199920174

The United States
comprises about
5% of the world’s
population but is
responsible for
80% of its opioid
consumption.2

5

Th e O p io id C risis
Each time an opioid
prescription is refilled
after surgery, the rate
of opioid misuse
increases by 44%5

6

Drug Overdose Death Rates by Category in the United
States from 1999-20174

2
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Orthopedic Surgery 6,7

Total knee
arthroplasty

Estimation exceeds
640,000 procedures
per year in U.S.

Total hip arthroplasty

Estimation exceeds
450,000 procedures
per year in U.S.

Procedures requiring
long-term
postoperative opioids

7

Solution

3

8

Cryotherapy
Application of cold
temperatures to the
effected tissues

Believed to have painlimiting effects through
multiple mechanisms

9
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Cryotherapy Physiology 8,9,10
Vasoconstriction
decreases blood
flow

Reduction of
inflammatory
response

Decreased
swelling and
pain

Slowed nerve
conduction
velocity

Decreased
stimulation sensed
by the brain

Decreased pain
sensation

Cooling of
synovial fluid

Decreased
prostaglandin

Limits pain

10

Literature Sum m ary
Brouwers et al8
• RCT
• Cryotherapy
resulted in a
48% reduction
in
postoperative
opioid
consumption

Kuyucu et al9
• RCT
• Cryotherapy
resulted in
lower
postoperative
pain scores and
less opioid
consumption

Thijs et al11
• RCT
• Cryotherapy
decreased
postoperative
consumption
by 57%.

11

Literature Sum m ary, cont.
Chughtai et al10
• Systematic review of 52
articles
• Cryotherapy decreased
pain scores and
postoperative opioid
consumption

12

Ni et al12
• Systematic review of 12
articles
• Cryotherapy reduces
pain scores and
decreased postoperative
opioid consumption

4
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Sum m ary
Deaths from opioid overdoses are rapidly
rising

Anesthesia professionals are at the
forefront of controlling pain while limiting
postoperative opioid consumption

Cryotherapy is a multimodal intervention
proven to limit postoperative opioid
consumption following orthopedic surgery

13

5

Thank You!
Cod y W ilson: cw ils089@ fiu.edu or (614) 937-6796
D r. Valerie D iaz: vdiaz@ fiu .edu or (305) 348-9027

14

References

15

1.

Dasgupta N, Beletsky L, Ciccarone D. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants. Am J Public Health. 2018;108(2):182-186.

2.

Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD. The Opioid Crisis: a Comprehensive Overview. Curr Pain Headache Rep. 2018;22(3):16.

3.

Guinot PG, Spitz A, Berthoud V, et al. Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched casecontrol study. BMC Anesthesiol. 2019;19(1):136.

4.

Hedegaard H, Miniño AM, Warner M. Drug Overdose Deaths in the United States, 1999-2017. NCHS Data Brief. 2018(329):1-8.

5.

Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort
study. Bmj. 2018;360:j5790.

6.

Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid
Epidemic. Anesth Analg. 2017;125(5):1733-1740.

7.

Ferket BS, Feldman Z, Zhou J, Oei EH, Bierma-Zeinstra SMA, Mazumdar M. Impact of total knee replacement practice: cost effectiveness analysis of
data from the Osteoarthritis Initiative. BMJ. 2017;356:j1131.

8.

Brouwers HFG, de Vries AJ, van Zuilen M, van Kouswijk HW, Brouwer RW. The role of computer-assisted cryotherapy in the postoperative treatment
after total knee arthroplasty: positive effects on pain and opioid consumption. Knee Surgery, Sports Traumatology, Arthroscopy. 2021.

9.

Kuyucu E, Bülbül M, Kara A, Koçyiğit F, Erdil M. Is cold therapy really efficient after knee arthroplasty? Annals of Medicine and Surgery. 2015;4(4):475478.

10.

Chughtai M, Elmallah RD, Mistry JB, et al. Nonpharmacologic pain management and muscle strengthening following total knee arthroplasty. The
journal of knee surgery. 2016;29(03):194-200.

11.

Thijs E, Schotanus MGM, Bemelmans YFL, Kort NP. Reduced opiate use after total knee arthroplasty using computer-assisted cryotherapy. Knee
Surgery, Sports Traumatology, Arthroscopy. 2019;27(4):1204-1212.

12.

Ni S-H, Jiang W-T, Guo L, et al. Cryotherapy on postoperative rehabilitation of joint arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy.
2015;23(11):3354-3361.

69
Appendix I
Pretest Results Report

Pretest Report
1. Which of these factors contributes to the complexity of modern day pain
management?

2. Each time a patient refills an opioid prescription after surgery, the rate of
opioid misuse increases by:
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3. The United States is responsible for what percentage of the world's opioid
use?

4. The majority of opioid abusers began their addictions from:

71

5. The procedures with the highest incidence of long-term postoperative opioid
consumption are: (Select 2)

6. Opioid-related complications that occur postoperatively have been shown to
increase the risk of hospital admission by what percentage?
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7. Which of these is believed to be one physiologic mechanism that accounts for
the effectiveness of cryotherapy in limiting pain?

8. The cooling of synovial fluid is believed to have what direct effect on limiting
pain?
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9. In randomized control trials, cryotherapy has been shown to reduce
postoperative opioid consumption by as much as:

10. How likely are you to consider using cryotherapy for postoperative pain
management in your anesthetic plan for orthopedic surgery cases?
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Appendix J
Posttest Results Report

Posttest Report
1. Which of these factors contributes to the complexity of modern day pain
management?

2. Each time a patient refills an opioid prescription after surgery, the rate of
opioid misuse increases by:
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3. The United States is responsible for what percentage of the world's opioid
use?

4. The majority of opioid abusers began their addictions from:
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5. The procedures with the highest postoperative opioid consumption are:
(Select 2)

6. Opioid-related complications that occur postoperatively have been shown to
increase the risk of hospital admission by what percentage?
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7. Which of these is believed to be one physiologic mechanism that accounts for
the effectiveness of cryotherapy in limiting pain?

8. The cooling of synovial fluid is believed to have what direct effect on limiting
pain?
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9. In randomized control trials, cryotherapy has been shown to reduce
postoperative opioid consumption by as much as:

10. How likely are you to consider using cryotherapy for postoperative pain
management in your anesthetic plan for orthopedic surgery cases?
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Appendix K
Combined Pre- and Post-Module Results
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Appendix L
CITI Certificates
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